These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30987746)

  • 41. Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods.
    Berlim MT; Turecki G
    Can J Psychiatry; 2007 Jan; 52(1):46-54. PubMed ID: 17444078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating atypical antipsychotics in the treatment of refractory depression.
    Thase ME
    J Clin Psychiatry; 2009 May; 70(5):e14. PubMed ID: 19552861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence-based pharmacotherapy of treatment-resistant unipolar depression.
    Dold M; Kasper S
    Int J Psychiatry Clin Pract; 2017 Mar; 21(1):13-23. PubMed ID: 27848269
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nefazodone therapy in patients with treatment-resistant or treatment-intolerant depression and high psychiatric comorbidity.
    Sajatovic M; DiGiovanni S; Fuller M; Belton J; DeVega E; Marqua S; Liebling D
    Clin Ther; 1999 Apr; 21(4):733-40. PubMed ID: 10363738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment for Depression and Health-Related Quality of Life among Adults with Arthritis.
    Shah D; Rai P; Dwibedi N; Sambamoorthi U
    Psychiatr Q; 2018 Mar; 89(1):129-140. PubMed ID: 28612178
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review.
    Stimpson N; Agrawal N; Lewis G
    Br J Psychiatry; 2002 Oct; 181():284-94. PubMed ID: 12356654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Challenges of Treatment-resistant Depression.
    Pandarakalam JP
    Psychiatr Danub; 2018 Sep; 30(3):273-284. PubMed ID: 30267518
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recognition and management of depression in primary care: a focus on the elderly. A pharmacotherapeutic overview of the selection process among the traditional and new antidepressants.
    Barkin RL; Schwer WA; Barkin SJ
    Am J Ther; 2000 May; 7(3):205-26. PubMed ID: 11317169
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of pharmaceutically treated depression and treatment resistant depression in South Korea.
    Kim N; Cho SJ; Kim H; Kim SH; Lee HJ; Park CHK; Rhee SJ; Kim D; Yang BR; Choi SH; Choi G; Koh M; Ahn YM
    PLoS One; 2019; 14(8):e0221552. PubMed ID: 31442296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment-resistant depression: no panacea, many uncertainties. Adverse effects are a major factor in treatment choice.
    Prescrire Int; 2011 May; 20(116):128-33. PubMed ID: 21648180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Frontiers in Therapy of Treatment-Resistant-Depression: A Future Role of Ketamine?
    Kwak S; Tiller D; Tucker P
    J Okla State Med Assoc; 2015 Mar; 108(3):88-9. PubMed ID: 26242015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Alternative approaches to refractory depression in bipolar illness.
    Post RM; Leverich GS; Denicoff KD; Frye MA; Kimbrell TA; Dunn R
    Depress Anxiety; 1997; 5(4):175-89. PubMed ID: 9338110
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biologically based treatment approaches to the patient with resistant perinatal depression.
    Robakis TK; Williams KE
    Arch Womens Ment Health; 2013 Oct; 16(5):343-51. PubMed ID: 23828097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antidepressants for older people: what can we learn from the current evidence base?
    Katona C; Bindman DC; Katona CP
    Maturitas; 2014 Oct; 79(2):174-8. PubMed ID: 24975955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Electroconvulsive therapy in therapy refractory depression in the elderly. Report of experiences].
    Wetterling T; Michels R; Dilling H
    Nervenarzt; 1998 Jul; 69(7):617-21. PubMed ID: 9715480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. How should we phrase the depression that is not responding to antidepressants? Treatment-refractory or treatment-resistant.
    Gonul AS
    J Affect Disord; 2019 Aug; 255():. PubMed ID: 30987746
    [No Abstract]   [Full Text] [Related]  

  • 59. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment strategy in depression. I. Non-tricyclic and selective reuptake inhibitors in resistant depression: a double-blind partial crossover study on the effects of oxaprotiline and fluvoxamine.
    Nolen WA; van de Putte JJ; Dijken WA; Kamp JS; Blansjaar BA; Kramer HJ; Haffmans J
    Acta Psychiatr Scand; 1988 Dec; 78(6):668-75. PubMed ID: 3146890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.